Cargando…

SGLT1/2 as the potential biomarkers of renal damage under Apoe(−/−) and chronic stress via the BP neural network model and support vector machine

BACKGROUND: Chronic stress (CS) could produce negative emotions. The molecular mechanism of SGLT1 and SGLT2 in kidney injury caused by chronic stress combined with atherosclerosis remains unclear. METHODS: In total, 60 C57BL/6J mice were randomly divided into four groups, namely, control (CON, n = 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Gai-feng, Wang, Xiang, Meng, Ling-bing, Li, Jian-yi, Xu, Hong-xuan, Wu, Di-shan, Shan, Meng-jie, Chen, Yu-hui, Xu, Jia-pei, Gong, Tao, Chen, Zuoguan, Li, Yong-jun, Liu, De-ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405420/ https://www.ncbi.nlm.nih.gov/pubmed/36035950 http://dx.doi.org/10.3389/fcvm.2022.948909

Ejemplares similares

A potential biomarker for clinical atherosclerosis: A novel insight derived from myosin heavy chain 10 promoting transformation of vascular smooth muscle cells
por: Meng, Ling‐bing, et al.
Publicado: (2022)

A Potential Target for Clinical Atherosclerosis: A Novel Insight Derived from TPM2
por: Meng, Ling-bing, et al.
Publicado: (2022)

Electrocardiographic changes associated with SGLT2 inhibitors and non-SGLT2 inhibitors: A multi-center retrospective study
por: Wu, Victor Chien-Chia, et al.
Publicado: (2022)

Benefits of SGLT2 inhibitors in arrhythmias
por: Gao, Jinghan, et al.
Publicado: (2022)

Adrenal SGLT1 or SGLT2 as predictors of atherosclerosis under chronic stress based on a computer algorithm
por: Li, Jianyi, et al.
Publicado: (2023)

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
por: Qiu, Mei, et al.
Publicado: (2021)

The ethanol extract of Edgeworthia gardneri (Wall.) Meisn attenuates macrophage foam cell formation and atherogenesis in ApoE(−/−) mice
por: Tang, Le, et al.
Publicado: (2022)

Varicose Veins and Risk of Venous Thromboembolic Diseases: A Two-Sample-Based Mendelian Randomization Study
por: Li, Ruihao, et al.
Publicado: (2022)

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
por: Capuano, Annalisa, et al.
Publicado: (2022)

Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality
por: Du, Lixin, et al.
Publicado: (2022)

Multi-omics insights into potential mechanism of SGLT2 inhibitors cardiovascular benefit in diabetic cardiomyopathy
por: Xi, Yangbo, et al.
Publicado: (2022)

Machine English Translation Evaluation System Based on BP Neural Network Algorithm
por: Han, Yanlin, et al.
Publicado: (2022)

Mechanical injury accentuates lipid deposition in ApoE(–/–) mice and advance aortic valve stenosis: A novel modified aortic valve stenosis model
por: Wen, Dezhong, et al.
Publicado: (2023)

SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study
por: Xu, Min, et al.
Publicado: (2022)

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study
por: Cesaro, Arturo, et al.
Publicado: (2022)

Endovascular repair of acute vs. subacute uncomplicated type B aortic dissection: a systematic review and meta-analysis
por: Zhao, WenXin, et al.
Publicado: (2023)

FOXK1 Participates in DNA Damage Response by Controlling 53BP1 Function
por: Tang, Mengfan, et al.
Publicado: (2020)

Meta-Analysis on the Safety and Cardiorenal Efficacy of SGLT2 Inhibitors in Patients Without T2DM
por: Li, Lu-Feng, et al.
Publicado: (2021)

Commentary: Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
por: Qiu, Mei, et al.
Publicado: (2021)

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology
por: Wang, Anzhu, et al.
Publicado: (2022)

Substantially different findings concerning the cardiovascular and cerebrovascular effectiveness of GLP1RAs vs. SGLT2is
por: Du, Lixin, et al.
Publicado: (2022)

Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
por: Lin, Xiao, et al.
Publicado: (2022)

Correlation of renal cortical blood perfusion and BP response after renal artery stenting
por: Wang, Siyu, et al.
Publicado: (2022)

GSVMA: A Genetic Support Vector Machine ANOVA Method for CAD Diagnosis
por: Hassannataj Joloudari, Javad, et al.
Publicado: (2022)

Momordica. charantia-Derived Extracellular Vesicles-Like Nanovesicles Protect Cardiomyocytes Against Radiation Injury via Attenuating DNA Damage and Mitochondria Dysfunction
por: Cui, Wen-Wen, et al.
Publicado: (2022)

The predictive value of pressure recording analytical method for the duration of mechanical ventilation in children undergoing cardiac surgery with an XGBoost-based machine learning model
por: Li, Mingwei, et al.
Publicado: (2022)

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia
por: Xu, Yitong, et al.
Publicado: (2022)

Is There a Diabetes–Kidney–Heart Continuum? Perspectives From the Results of the Cardiovascular and Renal Outcome Clinical Trials With SGLT2 Inhibitors
por: Bao, Liwen, et al.
Publicado: (2021)

Prediction of Bronchopneumonia Inpatients' Total Hospitalization Expenses Based on BP Neural Network and Support Vector Machine Models
por: Wu, Cuiyun, et al.
Publicado: (2022)

Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
por: Gager, Gloria M., et al.
Publicado: (2021)

Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status
por: Du, Lixin, et al.
Publicado: (2022)

The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients—a retrospective study
por: Zhu, Yi, et al.
Publicado: (2023)

IRF2BP2 3′UTR Polymorphism Increases Coronary Artery Calcification in Men
por: Vilmundarson, Ragnar O., et al.
Publicado: (2021)

The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE(−/−) Mice
por: Leng, Weiling, et al.
Publicado: (2016)

Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease
por: Zhang, Yao, et al.
Publicado: (2016)

Plasma Purification Treatment Relieves the Damage of Hyperlipidemia to PBMCs
por: Zhang, Xiao Meng, et al.
Publicado: (2021)

Effects of diagnostic ultrasound with cRGD-microbubbles on simultaneous detection and treatment of atherosclerotic plaque in ApoE(−/−) mice
por: Guo, Shengcun, et al.
Publicado: (2022)

SGLT2 Inhibitors Play a Salutary Role in Heart Failure via Modulation of the Mitochondrial Function
por: Maejima, Yasuhiro
Publicado: (2020)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis
por: Hua, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_doj9i5qetvfrmt3r50r5l28kuk